arrow_back Back to App

Opioid Addiction Treatment: Easier Access and New Rules

This act aims to make opioid addiction treatment, especially methadone, more accessible. It introduces changes that could shorten the waiting period for larger take-home doses and allow treatment in mobile units. It also permits methadone prescribing through pharmacies, potentially increasing therapy availability for patients.
Key points
Methadone Treatment: Patients may receive larger take-home doses sooner in their treatment.
Mobile Treatment Units: Addiction treatment programs can use mobile units to dispense medication.
Pharmacy Prescribing: Doctors can prescribe methadone for dispensing at pharmacies, potentially improving access to treatment.
Impact Study: A study will be conducted to assess how these rule changes affect patients and treatment programs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6279
Sponsor: Rep. Norcross, Donald [D-NJ-1]
Process start date: 2021-12-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Opioid Treatment Access Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6279.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-12-14.

What are the main provisions?

Key points include:

  • Methadone Treatment: Patients may receive larger take-home doses sooner in their treatment.
  • Mobile Treatment Units: Addiction treatment programs can use mobile units to dispense medication.
  • Pharmacy Prescribing: Doctors can prescribe methadone for dispensing at pharmacies, potentially improving access to treatment.
  • Impact Study: A study will be conducted to assess how these rule changes affect patients and treatment programs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Norcross, Donald [D-NJ-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health